Current approach to relapsed acute lymphoblastic leukemia in children

doi:10.5315/wjh.v3.i3.49

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17507)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

1575

WORD

411

HTML

11707

Figures (1-1)

185

Tables (1-6)

248

Sum=14126

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

568

Download

961

Sum=1529

Publishing Process of This Article

Item

Count

Browse

951

Download

901

Sum=1852

Aug 6, 2014 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hematol. Aug 6, 2014; 3(3): 49-70
Published online Aug 6, 2014. doi: 10.5315/wjh.v3.i3.49

Open in New Tab Full Size Figure Download Figure

Figure 1 Algorithm for the management of relapsed acute lymphoblastic leukaemia in children. Risk allocation is based on immunophenotype, time and site of relapse (see Table 5). SCT: Allogeneic stem cell transplantation; MRD: Minimal residual disease.

Citation: Fuster JL. Current approach to relapsed acute lymphoblastic leukemia in children. World J Hematol 2014; 3(3): 49-70
URL: https://www.wjgnet.com/2218-6204/full/v3/i3/49.htm
DOI: https://dx.doi.org/10.5315/wjh.v3.i3.49